|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 32.46 USD | -1.56% |
|
+1.35% | -9.78% |
| 03-31 | Indivior Pharmaceuticals, Inc. Announces Findings From Cost Impact Model For Monthly Injectable Buprenorphine | CI |
| 03-23 | Top Premarket Gainers | MT |
| Capitalization | 4.02B 3.41B 3.14B 2.96B 5.52B 375B 5.61B 36.83B 14.41B 180B 15.08B 14.77B 639B | P/E ratio 2026 * |
12.1x | P/E ratio 2027 * | 10.4x |
|---|---|---|---|---|---|
| Enterprise value | 3.8B 3.22B 2.97B 2.8B 5.23B 355B 5.31B 34.85B 13.64B 170B 14.27B 13.97B 604B | EV / Sales 2026 * |
3.28x | EV / Sales 2027 * | 2.95x |
| Free-Float |
96.11% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Indivior Pharmaceuticals, Inc.
| 1 day | -1.50% | ||
| 1 week | +1.35% | ||
| Current month | +6.20% | ||
| 1 month | +4.52% | ||
| 3 months | -1.57% | ||
| 6 months | +28.50% | ||
| Current year | -9.78% |
| 1 week | 30.11 |  | 33.62 |
| 1 month | 27.68 | | 33.62 |
| Current year | 27.68 | | 37.66 |
| 1 year | 8.69 | | 38 |
| 3 years | 7.33 | | 38 |
| 5 years | 7.33 | | 38 |
| 10 years | 1.75 | | 38 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.56% | +1.35% | +255.32% | +74.03% | 4.02B | |
| -2.40% | -6.30% | +17.96% | +139.88% | 825B | |
| -1.21% | -1.59% | +54.58% | +43.33% | 578B | |
| -0.89% | -2.59% | +16.58% | +27.88% | 372B | |
| -0.14% | +1.38% | +25.39% | +13.94% | 326B | |
| -1.02% | -2.96% | +43.64% | +24.88% | 314B | |
| -1.81% | -4.65% | +49.83% | +2.12% | 296B | |
| -1.61% | -2.34% | +31.20% | +34.32% | 294B | |
| -1.40% | -1.42% | +16.78% | +39.02% | 189B | |
| -0.96% | -2.02% | +31.23% | +65.83% | 174B | |
| Average | -1.21% | +1.35% | +54.25% | +46.52% | 337.33B | |
| Weighted average by Cap. | -1.35% | +0.30% | +32.05% | +57.25% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.16B 982M 906M 854M 1.59B 108B 1.62B 10.62B 4.16B 51.89B 4.35B 4.26B 184B | 1.22B 1.03B 954M 899M 1.68B 114B 1.7B 11.18B 4.38B 54.64B 4.58B 4.48B 194B |
| Net income | 353M 299M 276M 260M 485M 32.94B 493M 3.24B 1.27B 15.82B 1.33B 1.3B 56.15B | 413M 350M 322M 304M 567M 38.46B 576M 3.78B 1.48B 18.46B 1.55B 1.52B 65.56B |
| Net Debt | -216M -183M -169M -159M -297M -20.12B -301M -1.98B -774M -9.66B -810M -793M -34.31B | -412M -349M -322M -304M -567M -38.45B -576M -3.78B -1.48B -18.46B -1.55B -1.52B -65.54B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-04-15 | 32.34 $ | -1.91% | 319,531 |
| 26-04-14 | 32.97 $ | +4.34% | 1,274,336 |
| 26-04-13 | 31.60 $ | +3.47% | 1,497,635 |
| 26-04-10 | 30.54 $ | -5.48% | 2,347,819 |
| 26-04-09 | 32.31 $ | +1.16% | 918,346 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- INDV Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition